Drugs / ACHIM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02857257 | Jan 2015 → Dec 2018 | irritable bowel syndrome | Uppsala University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACHIM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02857257 ↗ |
| Modality | Other / unclassified | “We consider fecal microbiota transplantation in the form of ACHIM as an option for the future therapeutic armamentarium in IBS.” PMID 31594647 ↗ Apr 2019 |